Timothy Sullivan
2018
In 2018, Timothy Sullivan earned a total compensation of $859.8K as Chief Financial Officer at Apellis Pharmaceuticals, a 63% decrease compared to previous year.
Compensation breakdown
| Bonus | $190,000 |
|---|---|
| Option Awards | $279,250 |
| Salary | $380,000 |
| Other | $10,502 |
| Total | $859,752 |
Sullivan received $380K in salary, accounting for 44% of the total pay in 2018.
Sullivan also received $190K in bonus, $279.3K in option awards and $10.5K in other compensation.
Rankings
In 2018, Timothy Sullivan's compensation ranked 9,872nd out of 14,244 executives tracked by ExecPay. In other words, Sullivan earned more than 30.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,872 out of 14,244 | 31st |
Division Manufacturing | 3,992 out of 5,765 | 31st |
Major group Chemicals And Allied Products | 1,499 out of 2,128 | 30th |
Industry group Drugs | 1,264 out of 1,817 | 30th |
Industry Pharmaceutical Preparations | 971 out of 1,391 | 30th |
Source: SEC filing on April 30, 2019.
Sullivan's colleagues
We found four more compensation records of executives who worked with Timothy Sullivan at Apellis Pharmaceuticals in 2018.
News
Apellis Pharmaceuticals CEO Cedric Francois' 2021 pay slips 2% to $9.1M
April 20, 2022
Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
April 22, 2021
Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
April 22, 2020
Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
April 30, 2019